Treat-to-target approach in pulmonary arterial hypertension: a consensus-based proposal

Olivier Sitbon, Adolfo Baloira Villar, Fabrice Bauer, Björn Ekmehag, Wendy Gin-Sing, Kjell Jansson, David G. Kiely, Hanno Leuchte, Alessandra Manes, Stephan Rosenkranz, Pilar Escribano

Source: Eur Respir Rev 2012 21: 259-262
Journal Issue: September 2012 - 21 (125)
Disease area: Pulmonary vascular diseases

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Olivier Sitbon, Adolfo Baloira Villar, Fabrice Bauer, Björn Ekmehag, Wendy Gin-Sing, Kjell Jansson, David G. Kiely, Hanno Leuchte, Alessandra Manes, Stephan Rosenkranz, Pilar Escribano. Treat-to-target approach in pulmonary arterial hypertension: a consensus-based proposal. Eur Respir Rev 2012 21: 259-262

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The new definition of pulmonary hypertension
Source: Eur Respir J 2009; 34: 790-791
Year: 2009


Pulmonary hypertension: new guidelines for therapy
Source: Annual Congress 2007 - PG19 - Pulmonary vascular disorders: diagnosis and treatment
Year: 2007

Schistosomiasis-associated pulmonary arterial hypertension: a systematic review
Source: Eur Respir Rev, 29 (155) 190089; 10.1183/16000617.0089-2019
Year: 2020



Pulmonary arterial hypertension: treatment options
Source: International Congress 2018 – ME10 Pulmonary arterial hypertension: treatment options FULLY BOOKED
Year: 2018


Current medical treatment of pulmonary arterial hypertension
Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease
Year: 2018

Current medical treatment of pulmonary arterial hypertension
Source: School Course 2012 - Pulmonary hypertension and pulmonary vascular disease
Year: 2012



Current medical treatment of pulmonary arterial hypertension
Source: ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2017

Current medical treatment of pulmonary arterial hypertension
Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2014



Challenging the concept of adding more drugs in pulmonary arterial hypertension
Source: Eur Respir J, 50 (3) 1701527; 10.1183/13993003.01527-2017
Year: 2017



Applying pharmacogenomics to pulmonary arterial hypertension (PAH): A target-based approach to therapy
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments
Year: 2012


Identification of treatment goals in paediatric pulmonary arterial hypertension
Source: Eur Respir J 2014; 44: 1616-1626
Year: 2014



Pulmonary arterial hypertension: tailoring treatment to risk in the current era
Source: Eur Respir Rev, 26 (146) 170095; 10.1183/16000617.0095-2017
Year: 2017



An international survey of current pulmonary arterial hypertension (PAH) management
Source: Annual Congress 2012 - Pulmonary circulation: clinical PAH, registries and treatments
Year: 2012


Treatment options for paediatric pulmonary arterial hypertension
Source: Eur Respir Rev 2010 19: 321-330
Year: 2010



Learning from registries in pulmonary arterial hypertension: pitfalls and recommendations
Source: Eur Respir Rev, 28 (154) 190050; 10.1183/16000617.0050-2019
Year: 2019



Optimal management of severe pulmonary arterial hypertension
Source: Eur Respir Rev 2011; 20: 254-261
Year: 2011



Pulmonary hypertension and pulmonary arterial hypertension: a clarification is needed
Source: Eur Respir J 2010; 36: 986-990
Year: 2010


Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management
Source: Eur Respir J, 53 (1) 1801916; 10.1183/13993003.01916-2018
Year: 2019